Provectus Biopharmaceuticals, Inc. (PVCT) — SC 13D/A Filings
All SC 13D/A filings from Provectus Biopharmaceuticals, Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Provectus Biopharma Ownership Update
— Dec 6, 2024 Risk: medium
On December 6, 2024, an amendment (SC 13D/A) was filed regarding Provectus Biopharmaceuticals, Inc. The filing indicates a change in beneficial ownership by Per
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX